Sally Dabelsteen

Sally Dabelsteen

Associate Professor, Associate Professor - Promotion Programme

Member of:

    ORCID: 0000-0002-4279-8060

    Publication year:
    All
    1 - 3 out of 3Page size: 10
    1. 2023
    2. Published

      Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1

      Levann, Asha Maria Rudjord, Ye, Z., Hafkenscheid, L., Horn, S., Wiegertjes, R., Nielsen, Mathias Alexander Ingemann, Song, Ming, Mathiesen, C. B. K., Stoop, J., Stowell, S., Straten, P. T., Leffler, H., Vakhrushev, Sergey, Dabelsteen, Sally, Olsen, Jesper Velgaard & Wandall, Hans H., 2023, In: iScience. 26, 7, 21 p., 106984.

      Research output: Contribution to journal › Journal article › Research › peer-review

    3. Published

      Glycoengineered keratinocyte library reveals essential functions of specific glycans for all stages of HSV-1 infection

      Bagdonaite, Ieva , Marinova, I. N., Levann, Asha Maria Rudjord, Pallesen, E. M. H., King-Smith, S. L., Karlsson, R., Rømer, T. B., Chen, Yen-Hsi, Miller, Rebecca Louise, Olofsson, S., Nordén, R., Bergström, T., Dabelsteen, Sally & Wandall, Hans H., 2023, In: Nature Communications. 14, 19 p., 7000.

      Research output: Contribution to journal › Journal article › Research › peer-review

    4. Published

      Targeting Solid Cancers with a Cancer-Specific Monoclonal Antibody to Surface Expressed Aberrantly O-glycosylated Proteins

      Aasted, Mikkel Koed Møller, Groen, A. C., Keane, J. T., Dabelsteen, Sally, Tan, E., Schnabel, J., Liu, F., Lewis, H. G. S., Theodoropulos, C., Posey, A. D. & Wandall, Hans H., 2023, In: Molecular Cancer Therapeutics. 22, 10, p. 1204-1214 11 p.

      Research output: Contribution to journal › Journal article › Research › peer-review

    ID: 11286